The stock of cannabis company MedMen (CSE: MMEN) (OTCQX: MMNFF) is up about 10% as of the last day of January 2020 because of the announcement that their CEO Adam Bierman would resign. Both investors and the board of directors believe this move will “strengthen the governance” of the company moving forward.